{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:48:58Z","timestamp":1791578938621,"version":"4.3.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["MS240142"],"award-info":[{"award-number":["MS240142"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"DOI":"10.1038\/s41591-026-04665-3","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:02:41Z","timestamp":1789549361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["EBV reactivation priming of the peripheral immune system in multiple sclerosis relapse"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6485-2362","authenticated-orcid":false,"given":"Devin A.","family":"King","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3429-5671","authenticated-orcid":false,"given":"Shrishti","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3100-4085","authenticated-orcid":false,"given":"Danielle","family":"Caefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle C.","family":"Downer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Saucier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonmichael","family":"Aracena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4752-5142","authenticated-orcid":false,"given":"Alena","family":"Zhirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4529-9482","authenticated-orcid":false,"given":"Anthilia","family":"Alchanat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saoirse","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrishikesh","family":"Lokhande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard L.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3965-3418","authenticated-orcid":false,"given":"Benjamin E.","family":"Gewurz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9897-4422","authenticated-orcid":false,"given":"Tanuja","family":"Chitnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"4665_CR1","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton, C. et al. Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult. Scler. 26, 1816\u20131821 (2020).","journal-title":"Mult. Scler."},{"key":"4665_CR2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijid.2017.04.010","volume":"59","author":"S Jaijakul","year":"2017","unstructured":"Jaijakul, S., Salazar, L., Wootton, S. H., Aguilera, E. & Hasbun, R. The clinical significance of neutrophilic pleocytosis in cerebrospinal fluid in patients with viral central nervous system infections. Int. J. Infect. Dis. 59, 77\u201381 (2017).","journal-title":"Int. J. Infect. Dis."},{"key":"4665_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67504-6","volume":"10","author":"S Thebault","year":"2020","unstructured":"Thebault, S. et al. Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis. Sci. Rep. 10, 10381 (2020).","journal-title":"Sci. Rep."},{"key":"4665_CR4","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jamaneurol.2019.2137","volume":"76","author":"E Canto","year":"2019","unstructured":"Canto, E. et al. Association between serum neurofilament light chain levels and long-term disease course among patients with multiple sclerosis followed up for 12 years. JAMA Neurol. 76, 1359\u20131366 (2019).","journal-title":"JAMA Neurol."},{"key":"4665_CR5","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/acn3.638","volume":"5","author":"T Chitnis","year":"2018","unstructured":"Chitnis, T. et al. Neurofilament light chain serum levels correlate with 10-year MRI outcomes in multiple sclerosis. Ann. Clin. Transl. Neurol. 5, 1478\u20131491 (2018).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"4665_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42682-9","volume":"14","author":"J Akesson","year":"2023","unstructured":"Akesson, J. et al. Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis. Nat. Commun. 14, 6903 (2023).","journal-title":"Nat. Commun."},{"key":"4665_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48602-9","volume":"15","author":"T Chitnis","year":"2024","unstructured":"Chitnis, T. et al. Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis. Nat. Commun. 15, 4297 (2024).","journal-title":"Nat. Commun."},{"key":"4665_CR8","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","volume":"358","author":"SL Hauser","year":"2008","unstructured":"Hauser, S. L. et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 358, 676\u2013688 (2008).","journal-title":"N. Engl. J. Med."},{"key":"4665_CR9","doi-asserted-by":"crossref","first-page":"22932","DOI":"10.1073\/pnas.2008523117","volume":"117","author":"A Ramesh","year":"2020","unstructured":"Ramesh, A. et al. A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis. Proc. Natl Acad. Sci. USA 117, 22932\u201322943 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4665_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","volume":"603","author":"TV Lanz","year":"2022","unstructured":"Lanz, T. V. et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature 603, 321\u2013327 (2022).","journal-title":"Nature"},{"key":"4665_CR11","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","volume":"49","author":"SA Jenks","year":"2018","unstructured":"Jenks, S. A. et al. Distinct effector B cells induced by unregulated Toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus. Immunity 49, 725\u2013739 (2018).","journal-title":"Immunity"},{"key":"4665_CR12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cellimm.2017.07.003","volume":"321","author":"S Portugal","year":"2017","unstructured":"Portugal, S., Obeng-Adjei, N., Moir, S., Crompton, P. D. & Pierce, S. K. Atypical memory B cells in human chronic infectious diseases: an interim report. Cell Immunol. 321, 18\u201325 (2017).","journal-title":"Cell Immunol."},{"key":"4665_CR13","doi-asserted-by":"crossref","first-page":"1001145","DOI":"10.3389\/fimmu.2022.1001145","volume":"13","author":"ED SoRelle","year":"2022","unstructured":"SoRelle, E. D., Reinoso-Vizcaino, N. M., Horn, G. Q. & Luftig, M. A. Epstein-Barr virus perpetuates B cell germinal center dynamics and generation of autoimmune-associated phenotypes in vitro. Front. Immunol. 13, 1001145 (2022).","journal-title":"Front. Immunol."},{"key":"4665_CR14","volume":"6","author":"I Jelcic","year":"2025","unstructured":"Jelcic, I. et al. T-bet+ CXCR3+ B cells drive hyperreactive B-T cell interactions in multiple sclerosis. Cell Rep. Med. 6, 102027 (2025).","journal-title":"Cell Rep. Med."},{"key":"4665_CR15","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.4049\/jimmunol.1502448","volume":"197","author":"N Claes","year":"2016","unstructured":"Claes, N. et al. Age-associated B cells with proinflammatory characteristics are expanded in a proportion of multiple sclerosis patients. J. Immunol. 197, 4576\u20134583 (2016).","journal-title":"J. Immunol."},{"key":"4665_CR16","doi-asserted-by":"crossref","first-page":"e188543","DOI":"10.1172\/jci.insight.188543","volume":"10","author":"ED SoRelle","year":"2025","unstructured":"SoRelle, E. D. et al. Early multiple sclerosis activity associated with TBX21+CD21loCXCR3+ B cell expansion resembling EBV-induced phenotypes. JCI Insight 10, e188543 (2025).","journal-title":"JCI Insight"},{"key":"4665_CR17","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/acn3.52009","volume":"11","author":"S El Mahdaoui","year":"2024","unstructured":"El Mahdaoui, S. et al. CD11c+ B cells in relapsing-remitting multiple sclerosis and effects of anti-CD20 therapy. Ann. Clin. Transl. Neurol. 11, 926\u2013937 (2024).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"4665_CR18","doi-asserted-by":"crossref","first-page":"eaav7188","DOI":"10.1126\/science.aav7188","volume":"365","author":"International Multiple Sclerosis Genetics Consortium.","year":"2019","unstructured":"International Multiple Sclerosis Genetics Consortium. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science 365, eaav7188 (2019).","journal-title":"Science"},{"key":"4665_CR19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaut.2015.06.010","volume":"64","author":"JA Hollenbach","year":"2015","unstructured":"Hollenbach, J. A. & Oksenberg, J. R. The immunogenetics of multiple sclerosis: a comprehensive review. J. Autoimmun. 64, 13\u201325 (2015).","journal-title":"J. Autoimmun."},{"key":"4665_CR20","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/brain\/awx372","volume":"141","author":"I Smets","year":"2018","unstructured":"Smets, I. et al. Multiple sclerosis risk variants alter expression of co-stimulatory genes in B cells. Brain 141, 786\u2013796 (2018).","journal-title":"Brain"},{"key":"4665_CR21","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/gene.2010.10","volume":"11","author":"MC Cenit","year":"2010","unstructured":"Cenit, M. C. et al. STAT3 locus in inflammatory bowel disease and multiple sclerosis susceptibility. Genes Immun. 11, 264\u2013268 (2010).","journal-title":"Genes Immun."},{"key":"4665_CR22","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3389\/fimmu.2017.00425","volume":"8","author":"GP Parnell","year":"2017","unstructured":"Parnell, G. P. & Booth, D. R. The multiple sclerosis (MS) genetic risk factors indicate both acquired and innate immune cell subsets contribute to MS pathogenesis and identify novel therapeutic opportunities. Front. Immunol. 8, 425 (2017).","journal-title":"Front. Immunol."},{"key":"4665_CR23","doi-asserted-by":"crossref","first-page":"109847","DOI":"10.1016\/j.clim.2023.109847","volume":"257","author":"C Skarlis","year":"2023","unstructured":"Skarlis, C., Papadopoulos, V., Raftopoulou, S., Mavragani, C. P. & Evangelopoulos, M. E. B-cell activating factor gene variants in multiple sclerosis: possible associations with disease susceptibility among females. Clin. Immunol. 257, 109847 (2023).","journal-title":"Clin. Immunol."},{"key":"4665_CR24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103572","volume":"71","author":"JT Keane","year":"2021","unstructured":"Keane, J. T. et al. The interaction of Epstein-Barr virus encoded transcription factor EBNA2 with multiple sclerosis risk loci is dependent on the risk genotype. EBioMedicine 71, 103572 (2021).","journal-title":"EBioMedicine"},{"key":"4665_CR25","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1212\/WNL.0000000000001420","volume":"84","author":"R Mechelli","year":"2015","unstructured":"Mechelli, R. et al. Epstein-Barr virus genetic variants are associated with multiple sclerosis. Neurology 84, 1362\u20131368 (2015).","journal-title":"Neurology"},{"key":"4665_CR26","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2418783122","volume":"122","author":"R Mechelli","year":"2025","unstructured":"Mechelli, R. et al. A disease-specific convergence of host and Epstein\u2212Barr virus genetics in multiple sclerosis. Proc. Natl Acad. Sci. USA 122, e2418783122 (2025).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4665_CR27","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.autrev.2006.02.012","volume":"5","author":"SA Gauthier","year":"2006","unstructured":"Gauthier, S. A., Glanz, B. I., Mandel, M. & Weiner, H. L. A model for the comprehensive investigation of a chronic autoimmune disease: the multiple sclerosis CLIMB study. Autoimmun. Rev. 5, 532\u2013536 (2006).","journal-title":"Autoimmun. Rev."},{"key":"4665_CR28","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"4665_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51649-3","volume":"15","author":"PB Nicol","year":"2024","unstructured":"Nicol, P. B. et al. Robust identification of perturbed cell types in single-cell RNA-seq data. Nat. Commun. 15, 7610 (2024).","journal-title":"Nat. Commun."},{"key":"4665_CR30","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.celrep.2017.04.062","volume":"19","author":"I Ersing","year":"2017","unstructured":"Ersing, I. et al. A temporal proteomic map of Epstein-Barr virus lytic replication in B cells. Cell Rep. 19, 1479\u20131493 (2017).","journal-title":"Cell Rep."},{"key":"4665_CR31","doi-asserted-by":"crossref","first-page":"13028","DOI":"10.1128\/JVI.78.23.13028-13036.2004","volume":"78","author":"Y Chang","year":"2004","unstructured":"Chang, Y. et al. Induction of Epstein-Barr virus latent membrane protein 1 by a lytic transactivator Rta. J. Virol. 78, 13028\u201313036 (2004).","journal-title":"J. Virol."},{"key":"4665_CR32","doi-asserted-by":"crossref","first-page":"10427","DOI":"10.1128\/JVI.76.20.10427-10436.2002","volume":"76","author":"KL Carter","year":"2002","unstructured":"Carter, K. L., Cahir-McFarland, E. & Kieff, E. Epstein-barr virus-induced changes in B-lymphocyte gene expression. J. Virol. 76, 10427\u201310436 (2002).","journal-title":"J. Virol."},{"key":"4665_CR33","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1128\/JVI.79.7.4415-4424.2005","volume":"79","author":"N Ahsan","year":"2005","unstructured":"Ahsan, N., Kanda, T., Nagashima, K. & Takada, K. Epstein-Barr virus transforming protein LMP1 plays a critical role in virus production. J. Virol. 79, 4415\u20134424 (2005).","journal-title":"J. Virol."},{"key":"4665_CR34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.chom.2012.06.008","volume":"12","author":"A Arvey","year":"2012","unstructured":"Arvey, A. et al. An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions. Cell Host Microbe 12, 233\u2013245 (2012).","journal-title":"Cell Host Microbe"},{"key":"4665_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00281-020-00792-2","volume":"42","author":"A Buschle","year":"2020","unstructured":"Buschle, A. & Hammerschmidt, W. Epigenetic lifestyle of Epstein-Barr virus. Semin. Immunopathol. 42, 131\u2013142 (2020).","journal-title":"Semin. Immunopathol."},{"key":"4665_CR36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004656","volume":"11","author":"AM Price","year":"2015","unstructured":"Price, A. M. & Luftig, M. A. To be or not IIb: a multi-step process for Epstein-Barr virus latency establishment and consequences for B cell tumorigenesis. PLoS Pathog. 11, e1004656 (2015).","journal-title":"PLoS Pathog."},{"key":"4665_CR37","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik, K. et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 375, 296\u2013301 (2022).","journal-title":"Science"},{"key":"4665_CR38","doi-asserted-by":"crossref","first-page":"e1013898","DOI":"10.1371\/journal.ppat.1013898","volume":"22","author":"Y Sun","year":"2026","unstructured":"Sun, Y. et al. Epstein-barr virus latent membrane protein 1 targets cIAP1, cIAP2 and TRAF2 for proteasomal degradation to activate the non-canonical NF-\u03baB pathway. PLoS Pathog. 22, e1013898 (2026).","journal-title":"PLoS Pathog."},{"key":"4665_CR39","doi-asserted-by":"crossref","first-page":"e70090","DOI":"10.1002\/cbf.70090","volume":"43","author":"M Fujiwara","year":"2025","unstructured":"Fujiwara, M., Kondo, R., Sugiyama, Y., Maruyama, M. & Nishikimi, A. Increased Fascin1 and Pak1 expressions enhance age-associated B-cell actin cytoskeleton remodeling and motility. Cell Biochem. Funct. 43, e70090 (2025).","journal-title":"Cell Biochem. Funct."},{"key":"4665_CR40","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/imm.13598","volume":"168","author":"G Vidal-Pedrola","year":"2023","unstructured":"Vidal-Pedrola, G. et al. Characterization of age-associated B cells in early drug-naive rheumatoid arthritis patients. Immunology 168, 640\u2013653 (2023).","journal-title":"Immunology"},{"key":"4665_CR41","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2353\/ajpath.2008.070918","volume":"172","author":"EE McCandless","year":"2008","unstructured":"McCandless, E. E. et al. Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis. Am. J. Pathol. 172, 799\u2013808 (2008).","journal-title":"Am. J. Pathol."},{"key":"4665_CR42","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1084\/jem.20102010","volume":"208","author":"L Cruz-Orengo","year":"2011","unstructured":"Cruz-Orengo, L. et al. CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity. J. Exp. Med. 208, 327\u2013339 (2011).","journal-title":"J. Exp. Med."},{"key":"4665_CR43","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMra032015","volume":"350","author":"DA Thorley-Lawson","year":"2004","unstructured":"Thorley-Lawson, D. A. & Gross, A. Persistence of the Epstein\u2212Barr virus and the origins of associated lymphomas. N. Engl. J. Med. 350, 1328\u20131337 (2004).","journal-title":"N. Engl. J. Med."},{"key":"4665_CR44","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1093\/brain\/awp228","volume":"132","author":"M Comabella","year":"2009","unstructured":"Comabella, M. et al. A type I interferon signature in monocytes is associated with poor response to interferon-\u03b2 in multiple sclerosis. Brain 132, 3353\u20133365 (2009).","journal-title":"Brain"},{"key":"4665_CR45","doi-asserted-by":"crossref","first-page":"e1012341","DOI":"10.1371\/journal.ppat.1012341","volume":"20","author":"ED SoRelle","year":"2024","unstructured":"SoRelle, E. D. et al. Epstein-Barr virus reactivation induces divergent abortive, reprogrammed, and host shutoff states by lytic progression. PLoS Pathog. 20, e1012341 (2024).","journal-title":"PLoS Pathog."},{"key":"4665_CR46","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/s41579-019-0249-7","volume":"17","author":"C Munz","year":"2019","unstructured":"Munz, C. Latency and lytic replication in Epstein\u2212Barr virus-associated oncogenesis. Nat. Rev. Microbiol. 17, 691\u2013700 (2019).","journal-title":"Nat. Rev. Microbiol."},{"key":"4665_CR47","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ady0210","volume":"17","author":"S Younis","year":"2025","unstructured":"Younis, S. et al. Epstein-Barr virus reprograms autoreactive B cells as antigen-presenting cells in systemic lupus erythematosus. Sci. Transl. Med. 17, eady0210 (2025).","journal-title":"Sci. Transl. Med."},{"key":"4665_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1865-2","volume":"20","author":"Y Huang","year":"2019","unstructured":"Huang, Y., McCarthy, D. J. & Stegle, O. Vireo: Bayesian demultiplexing of pooled single-cell RNA-seq data without genotype reference. Genome Biol. 20, 273 (2019).","journal-title":"Genome Biol."},{"key":"4665_CR49","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1093\/bioinformatics\/btab358","volume":"37","author":"X Huang","year":"2021","unstructured":"Huang, X. & Huang, Y. Cellsnp-lite: an efficient tool for genotyping single cells. Bioinformatics 37, 4569\u20134571 (2021).","journal-title":"Bioinformatics"},{"key":"4665_CR50","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol. 42, 293\u2013304 (2024).","journal-title":"Nat. Biotechnol."},{"key":"4665_CR51","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 (2021).","journal-title":"Cell"},{"key":"4665_CR52","doi-asserted-by":"crossref","first-page":"979","DOI":"10.12688\/f1000research.73600.1","volume":"10","author":"PL Germain","year":"2021","unstructured":"Germain, P. L., Lun, A., Garcia Meixide, C., Macnair, W. & Robinson, M. D. Doublet identification in single-cell sequencing data using scDblFinder. F1000Res. 10, 979 (2021).","journal-title":"F1000Res."},{"key":"4665_CR53","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s42003-021-02146-6","volume":"4","author":"L He","year":"2021","unstructured":"He, L. et al. NEBULA is a fast negative binomial mixed model for differential or co-expression analysis of large-scale multi-subject single-cell data. Commun. Biol. 4, 629 (2021).","journal-title":"Commun. Biol."},{"key":"4665_CR54","doi-asserted-by":"publisher","unstructured":"Korotkevich, G. et al. Fast gene set enrichment analysis. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/060012 (2021).","DOI":"10.1101\/060012"},{"key":"4665_CR55","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"4665_CR56","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/cyto.a.22625","volume":"87","author":"S Van Gassen","year":"2015","unstructured":"Van Gassen, S. et al. FlowSOM: using self-organizing maps for visualization and interpretation of cytometry data. Cytometry A 87, 636\u2013645 (2015).","journal-title":"Cytometry A"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04665-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04665-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04665-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:03:14Z","timestamp":1791298994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04665-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":56,"alternative-id":["4665"],"URL":"https:\/\/doi.org\/10.1038\/s41591-026-04665-3","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of the article initially published, one of the GEO accession codes (","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"GSE347634","URL":"https:\/\/doi.org\/https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE347634","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":") was missing from the Data availability section. The Zenodo DOI (","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.5281\/zenodo.22806570","URL":"https:\/\/doi.org\/10.5281\/zenodo.22806570","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":") was also missing from both the Data and Code availability sections. These corrections have been made to the HTML and PDF versions of the article.","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.C. has received research support from the US Department of Defense, the National Institutes of Health, the National Multiple Sclerosis Society, Genentech Novartis, Octave Biosciences, Sanofi and Tiziana Life Sciences. She has served as a consultant\/advisory board member for Genentech, Lilly, Novartis, Octave Biosciences and Sanofi. H.L.W. has received research support from the Cure Alzheimer\u2019s Fund, the National Institutes of Health and the National Multiple Sclerosis Society. He has served on the advisory board for Sanofi and for Tiziana Life Sciences.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}